Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Saxagliptin (2.5mg) Tablet
Therapeutic Category
Antidiabetic, Diabetic
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Saxaplit 2.5 Tablet containing Saxagliptin is used for the management of type 2 diabetes mellitus. It helps improve blood sugar control and supports overall glycemic balance under medical supervision.
Saxagliptin works by inhibiting the DPP-4 enzyme, thereby increasing insulin release and reducing glucose production in the body.
The tablet is widely prescribed in endocrinology and general medicine practice for long-term diabetes management, leading to consistent prescription demand.
With increasing prevalence of diabetes and lifestyle-related metabolic disorders, this product offers strong business potential for retailers and distributors. Its established glycemic control action, broad clinical relevance, and steady market demand make it a reliable product for growth in the anti-diabetic segment.
Some patients may experience headache, upper respiratory tract infection, nausea, sinusitis, or mild gastrointestinal discomfort. Rarely, pancreatitis, allergic reactions, or joint pain may occur and require medical attention.
Saxaplit 2.5 Tablet is indicated for type 2 diabetes mellitus, either alone or in combination with other antidiabetic medicines. It helps lower fasting and post-meal blood sugar levels, improve insulin response, and support long-term glycemic control.
This medicine should be used under medical supervision along with diet control and exercise. Regular monitoring of blood glucose and kidney function is recommended. Use cautiously in patients with kidney or heart conditions.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : L-Arginine (3gm) + Proanthocyanidin (75mg) sachet
Composition : Carvedilol 12.5 tablet
Composition : Carvedilol CR 10mg Tablet
Composition : Carvedilol CR 20mg Tablet
Composition : Clopidogrel 150 mg Tablet
Composition : Pantoprazole (40mg)
Composition : Pantoprazole (80mg) Dual Release Gastro-Resistant
Composition : Clopidogrel 75 mg Tablet
Composition : Clopidogrel 75mg + Aspirin 150mg Tablet
Composition : Astaxanthin (16mg) + Reduced Coenzyme Q10 (200mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Saxaplit 2.5 Tablet, containing Saxagliptin 2.5mg, has strong demand in the antidiabetic segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on diabetes care and metabolic health portfolios.
Medical distributors and agencies can benefit from the consistent demand for DPP-4 inhibitor therapy used in type 2 diabetes management. Saxagliptin helps improve glycemic control with low risk of hypoglycemia, strengthening a comprehensive diabetes care product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Saxaplit 2.5 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from steady chronic diabetes prescription demand, long-term patient usage, reliable supply chain support, and good margins when partnering for Saxaplit 2.5 Tablet distribution.
Medical distributors, stockists, and wholesalers interested in Saxaplit 2.5 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.